The Medilink East Midlands Business Awards' "Deal of the Year" award recognizes the entrepreneurship of an individual or team in executing a truly transformational and high-value deal for both the company and the East Midlands Life Sciences sector.
Quotient Sciences won the award in recognition of securing a new private equity partner, Permira, with the investment providing substantial new funding to fuel the next stage of the Company's growth.
Mark Egerton, CEO of Quotient Sciences, commented: “We are delighted to win the Medilink Business Award which gives recognition to Quotient Sciences alongside our new partner, Permira, as we continue to drive the business forward."
"The Deal of the Year award is a great honor for our team, and achievements like this come from the hard work and dedication of all our staff. The investment by Permira will support our continued growth plans, which include broadening our core services portfolio and capabilities globally in order to meet the demands of our growing customer base.” continued Egerton.